Gaël Saint Olive advises French and foreign clients in international mergers and acquisitions and joint ventures, including multijurisdictional transactions involving coordination of legal teams in multiple countries.
He advised Sanofi in the creation of a joint venture with Lonza, the dismantlement of its European joint venture with Merck & Co. pertaining to vaccines, the sale of research sites and related research partnership and IP licenses to Evotec AG, the sale of various worldwide or multinational pharmaceutical businesses and of an African subsidiary, the acquisition of a leading generics manufacturer in Colombia, and the acquisition of pharmaceutical assets in Africa.
Other representative clients include: Solvay in the sale of one of its European divisions to Imerys; Simon Property Group in the acquisition of a 27.8 percent interest in Klépierre; Société de Financement Local (SFIL) in its creation as part of the market withdrawal of Dexia Crédit Local; and Caisse des Dépôts et Consignations in connection with several public-private partnerships and the High Museum in Atlanta in its partnership with Musée du Louvre.
Gaël is the Administrative Partner of the Firm's Paris Office.
- March 20, 2006
Dépénalisation, vous avez dit dépénalisation ?, Option Finance
Seminari e convegni
- 12 avril 2018
Finale de la 4ème édition du Prix Jones Day/Paris II/ESSEC
- 20 avril 2017
Finale de la 3ème édition du Prix Jones Day/ESSEC/Paris II
- 24 mai 2016
Réforme du droit des contrats et du droit des obligations - 1er volet : quel impact pour vos opérations M&A ?
- Georgetown University (LL.M. 1985); Institut d'Etudes Politiques de Paris (Sciences Po) (Diploma 1983); Ecole Normale Supérieure (1983); Université de Paris II-Panthéon Assas (DESS in Business Law and Taxation 1983; Maîtrise 1982); Université de Paris I-Panthéon Sorbonne (Licence en droit 1981)
- Paris Bar
Paris M&A team ranked Band 1 in "Mid-cap M&A" in France by Option Droit & Affaires (2015-2016)
Ranked yearly among the best corporate/M&A lawyers in France by The Legal 500 EMEA
- English, French